A molecular classification of congenital neutropenia syndromes

Pediatric Blood and Cancer

Volumn 49, Issue 5, 2007, Pages 609-614

  Boxer, Laurence A ^a   Newburger, Peter E ^b  

^a UNIVERSITY OF MICHIGAN   (United States)

^b UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

Author keywords

Agranulocytosis; Congenital neutropenia; Leukopenia; Primary immunodeficiency

Indexed keywords

ANTIBIOTIC AGENT; GRANULOCYTE COLONY STIMULATING FACTOR RECEPTOR; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; IMMUNOGLOBULIN A; IMMUNOGLOBULIN M; MITOCHONDRIAL DNA; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; RIBOSOME RNA;

AGAMMAGLOBULINEMIA; AGRANULOCYTOSIS; AUTOSOMAL DOMINANT INHERITANCE; AUTOSOMAL RECESSIVE INHERITANCE; BARTH SYNDROME; BONE DYSPLASIA; CARTILAGE HYPOPLASIA; CHEDIAK HIGASHI SYNDROME; COHEN SYNDROME; COMMON VARIABLE IMMUNODEFICIENCY; CONGENITAL NEUTROPENIA; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; DISEASE PREDISPOSITION; DISEASE SEVERITY; DYSKERATOSIS CONGENITA; GENE MUTATION; GLYCOGEN STORAGE DISEASE; GRANULOPOIESIS; GRISCELLI SYNDROME; HAIR DISEASE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; HYPERIMMUNOGLOBULINEMIA M; IMMUNE DEFICIENCY; IMMUNOGLOBULIN A DEFICIENCY; KOSTMANN DISEASE; LEUKEMIA; LEUKOCYTE COUNT; MYELODYSPLASIA; MYELOKATHEXIS; NEUTROPENIA; OCULAR ALBINISM; PATHOGENESIS; PEARSON SYNDROME; PERIPHERAL NEUROPATHY; PRIORITY JOURNAL; RECURRENT INFECTION; RETICULAR DYSGENESIS; REVIEW; SHWACHMAN SYNDROME; SYNDROME DELINEATION; WISKOTT ALDRICH SYNDROME; X CHROMOSOME LINKAGE; CLASSIFICATION; GENETICS; INHERITANCE; SYNDROME;

CLASSIFICATION; HUMANS; INHERITANCE PATTERNS; NEUTROPENIA; SYNDROME;

EID: 35148829886     PISSN: 15455009     EISSN: 15455017     Source Type: Journal    
DOI: 10.1002/pbc.21282     Document Type: Review

References (70)

1. Roper M, Parmley RT, Crist WM, et al. Severe congenital leukopenia (reticular dysgenesis). Immunologic and morphologic characterizations of leukocytes. Am J Dis Child 1985;139:832-835.
2. Bertrand Y, Muller SM, Casanova JL, et al. Reticular dysgenesis: HLA non-identical bone marrow transplants in a series of 10 patients. Bone Marrow Transplant 2002;29:759-762.
3. Dale DC, Hammond WP. Cyclic neutropenia: A clinical review. Blood Rev 1988;2:178-185.
4. Berliner N, Horwitz M, Loughran TP, Jr. Congenital and acquired neutropenia. Hematology (Am Soc Hematol Educ Program) 2004;63-79.
5. Palmer SE, Stephens K, Dale DC. Genetics, phenotype, and natural history of autosomal dominant cyclic hematopoiesis. Am J Med Genet 1996;66:413-422.
6. Dale DC, Cottle TE, Fier CJ, et al. Severe chronic neutropenia: Treatment and follow-up of patients in the Severe Chronic Neutropenia International Registry. Am J Hematol 2003;72:82-93.
7. Horwitz M, Benson KF, Person RE, et al. Mutations in ELA2, encoding neutrophil elastase, define a 21-day biological clock in cyclic haematopoiesis. Nat Genet 1999;23:433-436.
8. Dale DC, Bonilla MA, Davis MW, et al. A randomized controlled phase III trial of recombinant human granulocyte colony-stimulating factor (filgrastim) for treatment of severe chronic neutropenia. Blood 1993;81:2496-2502.
9. Kostmann R. Infantile genetic agranulocytosis; agranulocytosis infantilis hereditaria. Acta Paediatr 1956;45:1-78.
10. Boxer LA, Stein S, Buckley D, et al. Strong evidence for autosomal dominant inheritance of severe congenital neutropenia associated with ELA2 mutations. J Pediatr 2006;148:633-636.
11. Skokowa J, Germeshausen M, Zeidler C, et al. Severe congenital neutropenia: Inheritance and pathophysiology. Curr Opin Hematol 2007;14:22-28.
12. Boxer L, Dale DC. Neutropenia: Causes and consequences. Semin Hematol 2002;39:75-81.
13. Klein C, Grudzien M, Appaswamy G, et al. HAX1 deficiency causes autosomal recessive severe congenital neutropenia (Kostmann disease). Nat Genet 2006;39:86-92.
14. Welte K, Boxer LA. Severe chronic neutropenia: Pathophysiology and therapy. Semin Hematol 1997;34:267-278.
15. Bellanne-Chantelot C, Clauin S, Leblanc T, et al. Mutations in the ELA2 gene correlate with more severe expression of neutropenia: A study of 81 patients from the French Neutropenia Register. Blood 2004;103:4119-4125.
16. Dale DC, Person RE, Bolyard AA, et al. Mutations in the gene encoding neutrophil elastase in congenital and cyclic neutropenia. Blood 2000;96:2317-2322.
17. Aprikyan AA, Kutyavin T, Stein S, et al. Cellular and molecular abnormalities in severe congenital neutropenia predisposing to leukemia. Exp Hematol 2003;31:372-381.
18. Kollner I, Sodeik B, Schreek S, et al. Mutations in neutrophil elastase causing congenital neutropenia lead to cytoplasmic protein accumulation and induction of the unfolded protein response. Blood 2006;108:493-500.
19. Massullo P, Druhan LJ, Bunnell BA, et al. Aberrant subcellular targeting of the G185R neutrophil elastase mutant associated with severe congenital neutropenia induces premature apoptosis of differentiating promyelocytes. Blood 2005;105:3397-3404.
20. Person RE, Li FQ, Duan Z, et al. Mutations in proto-oncogene GFI1 cause human neutropenia and target E LA2. Nat Genet 2003;34:308-312.
21. Salipante SJ, Benson KF, Person RE, et al. Neutropenia-associated mutations of PFAAP5, a novel protein mediating transcriptional repressor interaction between Gfi1 and neutrophil elastase. Blood (ASH Annual Meeting Abstracts) 2006;108:Abstract 501.
22. Duan Z, Huang S, Person RE, et al. Neutropenia-associated mutations in PRDM5, a novel epigenetic regulator of hematopoiesis. Blood (ASH Annual Meeting Abstracts) 2006;108:Abstract 503.
23. Ward AC, van Aesch YM, Gits J, et al. Novel point mutation in the extracellular domain of the granulocyte colony-stimulating factor (G-CSF) receptor in a case of severe congenital neutropenia hyporesponsive to G-CSF treatment. J Exp Med 1999;190:497-507.
24. Skokowa J, Cario G, Uenalan M, et al. LEF-1 is crucial for neutrophil granulocytopoiesis and its expression is severely reduced in congenital neutropenia. Nat Med 2006;12:1191-1197.
25. Bonilla MA, Gillio AP, Ruggeiro M, et al. Effects of recombinant human granulocyte colony-stimulating factor on neutropenia in patients with congenital agranulocytosis. N Engl J Med 1989;320:1574-1580.
26. Freedman MH, Bonilla MA, Fier C, et al. Myelodysplasia syndrome and acute myeloid leukemia in patients with congenital neutropenia receiving G-CSF therapy. Blood 2000;96:429-436.
27. Germeshausen M, Ballmaier M, Welte K. Incidence of CSF3R mutations in severe congenital neutropenia and relevance for leukemogenesis: Results of a long-term survey. Blood 2007;109:93-99.
28. Donadieu J, Leblanc T, Bader MB, et al. Analysis of risk factors for myelodysplasias, leukemias and death from infection among patients with congenital neutropenia. Experience of the French Severe Chronic Neutropenia Study Group. Haematologica 2005;90:45-53.
29. Rosenberg PS, Alter BP, Bolyard AA, et al. The incidence of leukemia and mortality from sepsis in patients with severe congenital neutropenia receiving long-term G-CSF therapy. Blood 2006;107:4628-4635.
30. Donini M, Fontana S, Savoldi G, et al. G-CSF treatment of severe congenital neutropenia reverses neutropenia but does not correct the underlying functional deficiency of the neutrophil in defending against microorganisms. Blood 2007;109:4716-4723.
31. Dror Y, Freedman MH. Shwachman-Diamond syndrome. Br J Haematol 2002;118:701-713.
32. Boocock GR, Morrison JA, Popovic M, et al. Mutations in SBDS are associated with Shwachman-Diamond syndrome. Nat Genet 2003;33:97-101.
33. Shimamura A. Shwachman-Diamond syndrome. Semin Hematol 2006;43:178-188.
34. Dokal I. Dyskeratosis congenita in all its forms. Br J Haematol 2000;110:768-779.
35. Vulliamy TJ, Marrone A, Knight SW, et al. Mutations in dyskeratosis congenita: Their impact on telomere length and the diversity of clinical presentation. Blood 2006;107:2680-2685.
36. Marrone A, Walne A, Dokal I. Dyskeratosis congenita: Telomerase, telomeres and anticipation. Curr Opin Genet Dev 2005;15:249-257.
37. Vulliamy TJ, Walne A, Baskaradas A, et al. Mutations in the reverse transcriptase component of telomerase (TERT) in patients with bone marrow failure. Blood Cells Mol Dis 2005;34:257-263.
38. Mochizuki Y, He J, Kulkarni S, et al. Mouse dyskerin mutations affect accumulation of telomerase RNA and small nucleolar RNA, telomerase activity, and ribosomal RNA processing. Proc Natl Acad Sci USA 2004;101:10756-10761.
39. Vlachos A, Lipton JM. Hematopoietic stem cell transplant for inherited bone marrow failure syndromes. In: Mehter P, editor. Pediatric stem cell transplantation. Sudbury, MA: Jones and Bartlett; 2004: pp 281-311.
40. Barth PG, Wanders RJ, Vreken P, et al. X-linked cardioskeletal myopathy and neutropenia (Barth syndrome) (MIM 302060). J Inherit Metab Dis 1999;22:555-567.
41. Barth PG, Valianpour F, Bowen VM, et al. X-linked cardioskeletal myopathy and neutropenia (Barth syndrome): An update. Am J Med Genet Part A 2004;126A:349-354.
42. Kuijpers TW, Maianski NA, Tool AT, et al. Neutrophils in Barth syndrome (BTHS) avidly bind annexin-V in the absence of apoptosis. Blood 2004;103:3915-3923.
43. Melis D, Fulceri R, Parenti G, et al. Genotype/phenotype correlation in glycogen storage disease type 1b: A multicentre study and review of the literature. Eur J Pediatr 2005;164:501-508.
44. Kuijpers TW, Maianski NA, Tool AT, et al. Apoptotic neutrophils in the circulation of patients with glycogen storage disease type 1b (GSD1b). Blood 2003;101:5021-5024.
45. Pearson HA, Lobel JS, Kocoshis SA, et al. A new syndrome of refractory sideroblastic anemia with vacuolization of marrow precursors and exocrine pancreatic dysfunction. J Pediatr 1979;95:976-984.
46. Borregaard N, Boxer LA. Disorders of neutrophil function. In: Lichtman MA, Beutler E, Kipps TJ, Seligsohn U, Kaushansky K, Prchal JT, editors. Hematology. New York: McGraw-Hill Medical; 2006: pp 921-960.
47. Dell'angelica EC. Bad signals jam organelle traffic. Nat Med 2007;13:31-32.
48. Barbosa MD, Barrat FJ, Tchernev VT, et al. Identification of mutations in two major mRNA isoforms of the Chediak-Higashi syndrome gene in human and mouse. Hum Mol Genet 1997;6:1091-1098.
49. Spritz RA. Multi-organellar disorders of pigmentation: Tied up in traffic. Clin Genet 1999;55:309-317.
50. Tardieu M, Lacroix C, Neven B, et al. Progressive neurologic dysfunctions 20 years after allogeneic bone marrow transplantation for Chediak-Higashi syndrome. Blood 2005;106:40-42.
51. Kolehmainen J, Wilkinson R, Lehesjoki AE, et al. Delineation of Cohen syndrome following a large-scale genotype-phenotype screen. Am J Hum Genet 2004;75:122-127.
52. Griscelli C, Durandy A, Guy-Grand D, et al. A syndrome associating partial albinism and immunodeficiency. Am J Med 1978;65:691-702.
53. Menasche G, Pastural E, Feldmann J, et al. Mutations in RAB27A cause Griscelli syndrome associated with haemophagocytic syndrome. Nat Genet 2000;25:173-176.
54. Bahadoran P, Busca R, Chiaverini C, et al. Characterization of the molecular defects in Rab27a, caused by RAB27A missense mutations found in patients with Griscelli syndrome. J Biol Chem 2003;278:11386-11392.
55. Fontana S, Parolini S, Vermi W, et al. Innate immunity defects in Hermansky-Pudlak type 2 syndrome. Blood 2006;107:4857-4864.
56. Jung J, Bohn G, Allroth A, et al. Identification of a homozygous deletion in the AP3B1 gene causing Hermansky-Pudlak syndrome, type 2. Blood 2006;108:362-369.
57. Bohn G, Allroth A, Brandes G, et al. A novel human primary immunodeficiency syndrome caused by deficiency of the endosomal adaptor protein p14. Nat Med 2007;13:38-45.
58. Hermanns P, Tran A, Munivez E, et al. RMRP mutations in cartilage-hair hypoplasia. Am J Med Genet Part A 2006;140A:2121-2130.
59. Cham B, Bonilla MA, Winkelstein J. Neutropenia associated with primary immunodeficiency syndromes. Semin Hematol 2002;39:107-112.
60. Ferrari S, Giliani S, Insalaco A, et al. Mutations of CD40 gene cause an autosomal recessive form of immunodeficiency with hyper IgM. Proc Natl Acad Sci USA 2001;98:12614-12619.
61. Levy J, Espanol-Boren T, Thomas C, et al. Clinical spectrum of X-linked hyper-IgM syndrome. J Pediatr 1997;131:47-54.
62. Winkelstein JA, Marino MC, Ochs H, et al. The X-linked hyper-IgM syndrome: Clinical and immunologic features of 79 patients. Medicine (Baltimore) 2003;82:373-384.
63. Ogershok PR, Hogan MB, Welch JE, et al. Spectrum of illness in pediatric common variable immunodeficiency. Ann Allergy Asthma Immunol 2006;97:653-656.
64. Clewing JM, Antalfy BC, Lucke T, et al. Schimke immuno-osseous dysplasia: A clinicopathological correlation. J Med Genet 2007;44:122-130.
65. Boerkoel CF, Takashima H, John J, et al. Mutant chromatin remodeling protein SMARCAL1 causes Schimke immuno-osseous dysplasia. Nat Genet 2002;30:215-220.
66. Petty EM, Yanik GA, Hutchinson RJ, et al. Successful bone marrow transplantation in a patient with Schimke immuno-osseous dysplasia. J Pediatr 2000;137:882-886.
67. Latger-Cannard V, Bensoussan D, Bordigoni P. The WHIM syndrome shows a peculiar dysgranulopoiesis: Myelokathexis. Br J Haematol 2006;132:669.
68. Balabanian K, Lagane B, Pablos JL, et al. WHIM syndromes with different genetic anomalies are accounted for by impaired CXCR4 desensitization to CX CL12. Blood 2005;105:2449-2457.
69. Christopher MJ, Link DC. Regulation of neutrophil homeostasis. Curr Opin Hematol 2007;14:3-8.
70. Ancliff PJ, Blundell MP, Cory GO, et al. Two novel activating mutations in the Wiskott-Aldrich syndrome protein result in congenital neutropenia. Blood 2006;108:2182-2189.